Description:

This study is examining the effectiveness of a medication at treating the rebound illness. Patients must have been diagnosed with COVID-19 and have completed a 5-day course of Paxlovid treatment and experienced symptom relief. Qualifying rebound symptoms must occur within 14 days of completion of Paxlovid course. This study has 10 visits over a 24-week period.

Qualified Participants are: 

• Patients aged 12 years and older, who are suffering rebound symptoms from COVID-19 infection after being treated with Paxlovid.
  

Location:

4300 Clime Rd

Columbus, Ohio 43228

(614) 372-6857